Type
- ARTG (494)
- Cancellation by sponsor (465)
- Australian Public Assessment Report (AusPAR) (63)
- Prescription medicine registration (41)
- Section 14, TGO91 consent (21)
- Prescription medicine decision summary (19)
- Designation or determination (9)
- Cancellation or suspension (7)
- Prescription medicine evaluation (2)
Date
- 2024 (62)
- 2023 (73)
- 2022 (61)
- 2021 (126)
- 2020 (107)
- 2019 (98)
- 2018 (98)
- 2017 (74)
- 2016 (12)
- 2015 (22)
- 2014 (23)
- 2013 (9)
- 2012 (9)
- 2011 (14)
- 2010 (29)
- 2009 (13)
- 2008 (6)
- 2007 (12)
- 2006 (8)
- 2005 (4)
- 2004 (8)
- 2003 (9)
- 2002 (13)
- 2001 (8)
- 2000 (22)
- 1999 (12)
- 1998 (12)
- 1997 (18)
- 1996 (8)
- 1995 (3)
- 1994 (33)
- 1993 (19)
- 1992 (8)
- 1991 (88)
Results for
"[search-keyword]"
Sponsor content
1121 result(s) found, displaying 401 to 410
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PFIZER BUPIVACAINE 0.25% w/v WITH ADRENALINE (epinephrine) 1:400,000 injection solution vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BUPIVADREN Bupivacaine 0.25% w/v with Adrenaline (epinephrine) 1:400,000 injection solution vial.
-
PFIZER BUPIVACAINE 0.5% w/v WITH ADRENALINE (epinephrine) 1:200,000 injection solution vial (292527)
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PFIZER BUPIVACAINE 0.5% w/v WITH ADRENALINE (epinephrine) 1:200,000 injection solution vial. -
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BUPIVADREN Bupivacaine 0.5% w/v with Adrenaline (epinephrine) 1:200,000 injection solution vial.
-
Section 14, TGO91 consentProduct(s) approved for Supply with noncompliant labelling.
-
Section 14, TGO91 consentProduct(s) approved for Supply with noncompliant labelling.
-
Section 14, TGO91 consentProduct(s) approved for Supply with noncompliant labelling.
-
Section 14, TGO91 consentProduct(s) approved for Supply with noncompliant labelling.
-
Section 14, TGO91 consentProduct(s) approved for Supply with noncompliant labelling.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BICILLIN L-A-benzathine benzylpenicillin tetrahydrate 600,000 units/1.17 mL suspension for injection syringe with needle.